What causes itch in atopic dermatitis?

Itch, the hallmark of atopic dermatitis, has a significant impact on quality of life for patients with this disease. Various central and peripheral mediators have been suggested to play a role in the pathophysiology of atopic eczema itch. Significant cross-talk occurs among stratum corneum, keratinocytes, immune cells, and nerve fibers, which are in close proximity to one another and induce itch. The impaired barrier function associated with the itch-scratch cycle further augments this vicious cycle. Recent advances in our understanding of itch pathophysiology shed light on peripheral and central neural sensitization of nerve fibers that contribute significantly to itch in atopic dermatitis. Recently, several new mediators have been described as associated with itch in atopic dermatitis, including serine proteases, interleukin 31, and nerve growth factor. This review covers the peripheral and central mechanisms and mediators involved in pathogenesis of itch in atopic dermatitis.

[1]  R. Paus,et al.  TRP channels as novel players in the pathogenesis and therapy of itch. , 2007, Biochimica et biophysica acta.

[2]  Steve Davidson,et al.  The Itch-Producing Agents Histamine and Cowhage Activate Separate Populations of Primate Spinothalamic Tract Neurons , 2007, The Journal of Neuroscience.

[3]  V. Rogiers,et al.  Sustained serine proteases activity by prolonged increase in pH leads to degradation of lipid processing enzymes and profound alterations of barrier function and stratum corneum integrity. , 2005, The Journal of investigative dermatology.

[4]  R. Coghill,et al.  Repetitive scratching and noxious heat do not inhibit histamine‐induced itch in atopic dermatitis , 2007, The British journal of dermatology.

[5]  J. Rees,et al.  Involvement of histamine H4 and H1 receptors in scratching induced by histamine receptor agonists in BalbC mice , 2004, British journal of pharmacology.

[6]  H. Maibach,et al.  Time-dependent variations of the skin barrier function in humans: transepidermal water loss, stratum corneum hydration, skin surface pH, and skin temperature. , 1998, The Journal of investigative dermatology.

[7]  Paul J. Smith,et al.  Principal Components Representation of the Two-Dimensional Coronal Tongue Surface , 2002, Phonetica.

[8]  G. Yosipovitch,et al.  Nocturnal itch: why do we itch at night? , 2007, Acta dermato-venereologica.

[9]  M. Boguniewicz.  Atopic dermatitis: beyond the itch that rashes. , 2005, Immunology and allergy clinics of North America.

[10]  Thomas A. Luger,et al.  Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin , 2003, The Journal of Neuroscience.

[11]  M. Schmelz,et al.  Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. , 2002, Journal of the American Academy of Dermatology.

[12]  H. Stammer,et al.  Treatment of pruritus with topically applied opiate receptor antagonist. , 2007, Journal of the American Academy of Dermatology.

[13]  M. Akiyama,et al.  Oncostatin M receptor-beta mutations underlie familial primary localized cutaneous amyloidosis. , 2008, American journal of human genetics.

[14]  M. Steinhoff,et al.  Pathophysiology of pruritus in atopic dermatitis: an overview , 2002, Experimental dermatology.

[15]  H. Handwerker,et al.  Histamine-induced itch and alloknesis (itchy skin) in atopic eczema patients and controls. , 1995, Acta dermato-venereologica.

[16]  R. Coghill,et al.  Scratching and noxious heat stimuli inhibit itch in humans: a psychophysical study , 2007, The British journal of dermatology.

[17]  J. Salomon,et al.  The role of selected neuropeptides in pathogenesis of atopic dermatitis , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  Francis McGlone,et al.  Itch : Basic Mechanisms and Therapy , 2004 .

[19]  M. Steinhoff,et al.  IL-31: a new link between T cells and pruritus in atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.

[20]  M. Steinhoff,et al.  The neurobiology of itch , 2006, Nature Reviews Neuroscience.

[21]  Hermann O. Handwerker,et al.  Specific C-Receptors for Itch in Human Skin , 1997, The Journal of Neuroscience.

[22]  H. Korting,et al.  The pH of the Skin Surface and Its Impact on the Barrier Function , 2006, Skin Pharmacology and Physiology.

[23]  Matthias Ringkamp,et al.  Psychophysical and Physiological Evidence for Parallel Afferent Pathways Mediating the Sensation of Itch , 2007, The Journal of Neuroscience.

[24]  P. Desai,et al.  Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. , 2007, The Journal of allergy and clinical immunology.

[25]  R. Paus,et al.  Frontiers in pruritus research: scratching the brain for more effective itch therapy. , 2006, The Journal of clinical investigation.

[26]  P. Klein,et al.  An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. , 1999, Archives of dermatology.

[27]  M. Steinhoff,et al.  Activation of proteinase-activated receptor-2 by human kallikrein-related peptidases. , 2008, The Journal of investigative dermatology.

[28]  K. Takamori,et al.  Possible roles of epidermal opioid systems in pruritus of atopic dermatitis. , 2007, The Journal of investigative dermatology.

[29]  Robert C Coghill,et al.  The brain processing of scratching. , 2008, The Journal of investigative dermatology.

[30]  M. Schmelz,et al.  Bradykinin is a potent pruritogen in atopic dermatitis: A switch from pain to itch , 2006, Pain.

[31]  H. Akiyama,et al.  Psychological Stress can Trigger Atopic Dermatitis in NC/Nga Mice: An Inhibitory Effect of Corticotropin-Releasing Factor , 2008, Neuropsychopharmacology.

[32]  A. Slominski.  A nervous breakdown in the skin: stress and the epidermal barrier. , 2007, The Journal of clinical investigation.

[33]  T. Makino,et al.  Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis , 2002, The British journal of dermatology.

[34]  M. Mihara,et al.  Cutaneous nerves in atopic dermatitis , 1998, Virchows Archiv.

[35]  M. Schmelz,et al.  Influence of vagus nerve stimulation on histamine-induced itching , 2002, Neurology.

[36]  G. Yosipovitch.  The pruritus receptor unit: a target for novel therapies. , 2007, The Journal of investigative dermatology.

[37]  A. Naukkarinen,et al.  Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema , 2003, Archives of Dermatological Research.

[38]  G. Yosipovitch.  Dry skin and impairment of barrier function associated with itch – new insights , 2004, International journal of cosmetic science.

[39]  H. Yu,et al.  Transepidermal water loss, serum IgE and β‐endorphin as important and independent biological markers for development of itch intensity in atopic dermatitis , 2006, The British journal of dermatology.

[40]  M. Graeber,et al.  The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis , 2001, Experimental dermatology.

[41]  H. Renz,et al.  Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. , 2005, The Journal of allergy and clinical immunology.

[42]  S. Nakaike,et al.  Putative mechanism of the itch-scratch circle: repeated scratching decreases the cutaneous level of prostaglandin D2, a mediator that inhibits itching. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[43]  S. Hunt,et al.  Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. , 2008, The Journal of investigative dermatology.

[44]  R. LaMotte,et al.  Psychophysical studies of the itch sensation and itchy skin ("alloknesis") produced by intracutaneous injection of histamine. , 1991, Somatosensory & motor research.

[45]  H. Nojima,et al.  Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice. , 2007, The Journal of investigative dermatology.

[46]  Colin N A Palmer,et al.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.

[47]  R. Rukwied,et al.  Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients , 1999, Experimental dermatology.

[48]  Irene Tracey,et al.  Itch and motivation to scratch: an investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans. , 2007, Journal of neurophysiology.

[49]  M. Steinhoff,et al.  Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus. , 2006, The Journal of investigative dermatology.